OCD Medications: How Antidepressants and Antipsychotics Can Help

a variety of OCD medications sitting on a table

Jose A. Bernat Bacete / Moment Open / Getty Images

Table of Contents
View All
Table of Contents

What is the most important information I should know about OCD medications?

  • Tell your physician about any medications, supplements, or substances you are currently taking before starting a new OCD medication.
  • Never stop taking your medication suddenly; doing so may lead to withdrawal or a worsening of condition symptoms.

Obsessive-compulsive disorder (OCD) is commonly treated with both medication and cognitive behavioral therapy. Medications that target serotonin pathways in the brain, like antidepressants, are particularly effective in treating people with OCD—and if this doesn't work, adding on an antipsychotic medication may be useful.

Let's take a look at the various medications used to treat OCD, including antidepressants and antipsychotics, that have been found to be effective in scientific studies.

Antidepressant OCD Medications

Around 70% of people with OCD experience some benefit from medication, with a symptom reduction rate between 40% to 60%. The most commonly prescribed type of antidepressant medication used to treat OCD is selective serotonin reuptake inhibitors (SSRIs).

Though traditionally used to treat depression, research has shown SSRIs to be the most effective medications for OCD, as well. Their positive effects can often be felt within two weeks of starting treatment.

FDA-Approved SSRIs for OCD

Four SSRIs are approved by the Food and Drug Administration (FDA) to treat OCD in adults:

  • Luvox (fluvoxamine)
  • Paxil (paroxetine)
  • Prozac (fluoxetine)
  • Zoloft (sertraline)

If you do not respond to SSRIs, your doctor may prescribe Anafranil (clomipramine). Anafranil is a tricyclic antidepressant that is FDA-approved to treat OCD. Anafranil may cause side effects such as dry mouth, drowsiness, gastrointestinal issues, and trouble concentrating, among others.

Dosages

When treating OCD, SSRI doses are usually higher than those used for depression. Your primary care provider will probably start you on a low dose to begin and increase it if needed.

The daily dosing of SSRIs for OCD are as follows:

Medication Starting (mg/day) Target (mg/day)
Luvox  50  300 
Paxil 20  60
Prozac 20  80
Zoloft 50  200 

Check your prescription and talk to your physician to make sure you are taking the right dose for you. If after about 12 weeks your symptoms haven't decreased by about 40% to 50%, they may either adjust your dosage or start you on a different SSRI.

Off-Label SSRIs for OCD

Most people will experience at least some symptom relief after taking the antidepressants approved for OCD. Many still have residual symptoms, though.

In these situations, healthcare professionals may prescribe other medications "off-label" to try to find a more effective treatment. Two SSRIs—Celexa (citalopram) and Lexapro (escitalopram)—are sometimes prescribed off-label to treat OCD.

Off-Label SNRIs for OCD


Research also shows two serotonin-norepinephrine reuptake inhibitors (SNRIs), specifically Cymbalta (duloxetine) and Effexor (venlafaxine), to be just as effective as first-line medications.

Side Effects

Like all psychiatric medications, antidepressant OCD medications may cause side effects. Common side effects of antidepressants include:

In many cases, these side effects decrease over time as your body adjusts to your medication. Always talk to your physician about the side effects you are experiencing and any concerns you may have.

When Antidepressants Aren't Enough

About 40% to 60% of people with OCD do not show a satisfactory response to SSRIs alone. Generally speaking, "response" is defined as a 35% reduction in the Yale-Brown Obsessive-Compulsive Scale (a test that rates the severity of OCD symptoms; Y-BOCS).

If after 10 to 12 weeks SSRIs aren't significantly alleviating your symptoms, your physician may decide to try augmenting your SSRI with an antipsychotic. Augmenting involves adding a medication, in this case an antipsychotic, to improve the effectiveness of the original treatment.

When to Augment

Augmentation therapy is usually only implemented if Anafranil or SSRIs fail to improve OCD symptoms after at least three months.

Antipsychotic OCD Medications

Two types of antipsychotic medications can be used to treat OCD: first-generation and second-generation antipsychotics. Second-generation antipsychotics, also known as atypical antipsychotic medications, are usually chosen to augment SSRIs.

The following atypical antipsychotics have been found to work well:

  • Abilify (aripiprazole)
  • Risperdal (risperidone)
  • Seroquel (quetiapine)
  • Zyprexa (olanzapine)

Haldol (haloperidol), a first-generation antipsychotic, may also be used to augment SSRIs in people with OCD. Though Haldol can effectively treat OCD symptoms, it's been shown to be more likely to cause extrapyramidal side effects (drug-induced movement disorders) in some people than the atypical antipsychotics.

Dosages

There are no specific dosing recommendations for antipsychotic augmentation for OCD. Many experts believe antipsychotics should only be administered in low to medium doses. However, according to some studies, medium to higher dosages are more effective.

Below are some typical dose ranges for antipsychotic augmentation, although actual effective dosages can be different.

Medication Effective Range (mg/day)
Abilify 15-30
Risperdal 1-2
Seroquel 150-600
Zyprexa 5-10

Experts do agree, however, that using an antipsychotic to augment OCD treatment is nothing like using it for schizophrenia or bipolar disorder. Usually, much lower doses can be used to help treat OCD. In the end, it is really up to your physician to decide the appropriate dose needed to treat your symptoms.

When using an antipsychotic to augment OCD treatment, it's a good idea to start with a lower dosage. At high doses, some atypical antipsychotics may worsen OCD symptoms.

Side Effects

Antipsychotic medications also have the potential to cause side effects. Some of these include:

Antipsychotic medications are associated with an increased risk for tardive dyskinesia, a movement disorder that causes uncontrollable movements. It also increases the risk of akathisia, which leads to restlessness and an inability to be still.

Timeline and Withdrawal

Don't expect antipsychotics to immediately impact your symptoms of OCD. You may notice improvements within the first few days of taking these medications. However, it usually takes several weeks to fully experience their benefits.

Some guidelines recommend you take an antipsychotic for at least one year after symptom remission. Discontinuing earlier than that may increase your chances of relapse.

Never stop taking an antipsychotic or change the amount you are taking without your physician's approval, even if you feel better. Depending on which antipsychotic you're taking, this can lead to unwanted effects and problems managing your illness.

OCD Discussion Guide

Get our printable guide to help you ask the right questions at your next doctor's appointment.

Mind Doc Guide
17 Sources
Verywell Mind uses only high-quality sources, including peer-reviewed studies, to support the facts within our articles. Read our editorial process to learn more about how we fact-check and keep our content accurate, reliable, and trustworthy.
  1. Pittenger C, Bloch MH. Pharmacological treatment of obsessive-compulsive disorderPsychiatr Clin North Am. 2014;37(3):375–391. doi:10.1016/j.psc.2014.05.006

  2. International OCD Foundation. Medications for OCD.

  3. Issari Y, Jakubovski E, Bartley CA, Pittenger C, Bloch MH. Early onset of response with selective serotonin reuptake inhibitors in obsessive-compulsive disorder: a meta-analysis. J Clin Psychiatry. 2016;77(5):e605-11. doi:10.4088/JCP.14r09758

  4. Paxos C. Moving beyond first-line treatment options for OCD. Ment Health Clin. 2022;12(5):300-308. doi:10.9740/mhc.2022.10.300

  5. National Library of Medicine. Clomipramine.

  6. Khan SA. Drug therapy for obsessive-compulsive disorder. US Pharm. 2023;48(5):8-12.

  7. Külz AK, Landmann S, Cludius B, et al. Mindfulness-based cognitive therapy (MBCT) in patients with obsessive-compulsive disorder (OCD) and residual symptoms after cognitive behavioral therapy (CBT): a randomized controlled trialEur Arch Psychiatry Clin Neurosci. 2019;269(2):223-233. doi:10.1007/s00406-018-0957-4

  8. Del Casale A, Sorice S, Padovano A, et al. Psychopharmacological treatment of obsessive-compulsive disorder (OCD)Curr Neuropharmacol. 2019;17(8):710-736. doi:10.2174/1570159X16666180813155017

  9. Santarsieri D, Schwartz T. Antidepressant efficacy and side-effect burden: a quick guide for clinicians. Drugs Context. 2015;4:212290. doi:10.7573/dic.212290

  10. Rostami R, Kazemi R, Jabbari A, et al. Efficacy and clinical predictors of response to rTMS treatment in pharmacoresistant obsessive-compulsive disorder (OCD): a retrospective study. BMC Psychiatry. 2020;20:372. doi:10.1186/s12888-020-02769-9

  11. Thamby A, Jaisoorya TS. Antipsychotic augmentation in the treatment of obsessive-compulsive disorder. Indian J Psychiatry. 2019;61(Suppl 1):S51-S57. doi:10.4103/psychiatry.IndianJPsychiatry_519_18

  12. Fineberg NA, Reghunandanan S, Simpson HB, et al. Obsessive-compulsive disorder (OCD): Practical strategies for pharmacological and somatic treatment in adults. Psychiatry Res. 2015;227(1):114-125. doi:10.1016/j.psychres.2014.12.003

  13. Conti D, Girone N, Boscacci M, et al. The use of antipsychotics in obsessive compulsive disorder. Human Psychopharmacol Clin Exp. 2024;39(3):e2893. doi:10.1002/hup.2893

  14. Leung J, Palmer B. Psychosis or obsessions? Clozapine associated with worsening obsessive-compulsive symptoms. Case Rep Psychiatry. 2016:2180748. doi:10.1155/2016/2180748

  15. Cleveland Clinic. Antipsychotic medications.

  16. Bommarito S, Morris M. The role of antipsychotics in OCD. Anxiety & Depression Association of America.

  17. Longden E, Read J. Assessing and reporting the adverse effects of antipsychotic medication: A systematic review of clinical studies, and prospective, retrospective, and cross-sectional research. Clin Neuropharmacol. 2016;39(1):29-39. doi:10.1097/WNF.0000000000000117

By Owen Kelly, PhD
Owen Kelly, PhD, is a clinical psychologist, professor, and author in Ontario, ON, who specializes in anxiety and mood disorders.